Skip to content

Patient survey reveals 77% of medical cannabis patients see quality of life improvements.

12 February 2021

Following up on last month’s TMCC patient database publication, in which we provided an overview of the initial 1,500 medical cannabis patients under our care, it’s perhaps even more meaningful to have a look at the feedback provided by some of these patients. 

The headline figure from our latest patient survey is fairly clear and compelling. Of more than two hundred respondents, across the range of treatable conditions and symptoms, 77% of patients reported that medical cannabis care improved their quality of life to a substantial degree, or that they were feeling better. 

Only 18% of patients reported that care had little or no impact on their health or well-being, and a very small minority, 1.5%, reported that treatments had an adverse impact. Where patients did not receive a clear clinical benefit from medical cannabis care, treatments were discontinued. 

While generalised data, this is a highly positive finding that only adds strong support to the established case for medical cannabis care. 

As TMCC continues to open access for patients, we’ll be able to provide further and deeper analysis into patient survey results, and hopefully create the impetus needed for the NHS to take a more inclusive and supportive approach to medical cannabis. 

These results are an excellent benchmark for TMCC in the meantime. We are proud to be leading the medical cannabis field, and helping our patients with safe and effective care.

If you’d like to book a consultation, you can find our form here. Alternatively, contact us via our chat box at the bottom right hand corner of this page.

Author: Bojan
Author page

Bojan Ambrus, Head of Marketing & Digital Product at Lyphe Group, is a data-driven growth marketing professional with over 15 years of rich experience. His background includes roles such as Head of Marketing at and growth marketing roles in various enterprises, startups, and scale-ups. His expertise in building and positioning businesses is particularly valuable in the cannabis sector, where he navigates its complexities and regulatory challenges. His strategic marketing insights make Bojan a key player in shaping Lyphe Group's marketing and digital product strategies.

Latest posts

Become a patient today

Ready to start your journey?

Check if you are eligible
Start your journey in getting treated with medical cannabis
Get Started
Speak to an advisor
Free appointment with our expert Patient Advisor
Speak to an advisor